CIBC Asset Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Sell |
34,505
-351
| -1% | -$19K | 0.01% | 633 |
|
|
2026
Q1 | $1.82M | Buy |
34,856
+251
| +0.7% | +$15.1K | ﹤0.01% | 649 |
|
|
2025
Q4 | $2.04M | Buy |
34,605
+14,633
| +73% | +$889K | ﹤0.01% | 637 |
|
|
2025
Q3 | $1.11M | Sell |
19,972
-22
| -0.1% | -$1.18K | ﹤0.01% | 659 |
|
|
2025
Q2 | $1.03M | Sell |
19,994
-3,830
| -16% | -$192K | ﹤0.01% | 663 |
|
|
2025
Q1 | $1.4M | Sell |
23,824
-349
| -1% | -$23.7K | ﹤0.01% | 635 |
|
|
2024
Q4 | $1.74M | Buy |
24,173
+1,214
| +5% | +$89.1K | 0.01% | 603 |
|
|
2024
Q3 | $1.84M | Buy |
22,959
+1,718
| +8% | +$129K | 0.01% | 594 |
|
|
2024
Q2 | $1.52M | Sell |
21,241
-968
| -4% | -$71.2K | 0.01% | 606 |
|
|
2024
Q1 | $1.56M | Buy |
22,209
+571
| +3% | +$40.9K | 0.01% | 617 |
|
|
2023
Q4 | $1.67M | Sell |
21,638
-612
| -3% | -$40.3K | 0.01% | 585 |
|
|
2023
Q3 | $1.51M | Sell |
22,250
-349
| -2% | -$27.6K | 0.01% | 584 |
|
|
2023
Q2 | $1.84M | Sell |
22,599
-226
| -1% | -$18.2K | 0.01% | 565 |
|
|
2023
Q1 | $1.69M | Buy |
22,825
+390
| +2% | +$30.1K | 0.01% | 588 |
|
|
2022
Q4 | $1.86M | Buy |
22,435
+1,623
| +8% | +$129K | 0.01% | 558 |
|
|
2022
Q3 | $1.48M | Buy |
20,812
+1,824
| +10% | +$158K | 0.01% | 605 |
|
|
2022
Q2 | $1.65M | Buy |
18,988
+4,200
| +28% | +$394K | 0.01% | 565 |
|
|
2022
Q1 | $1.6M | Buy |
14,788
+144
| +1% | +$14.9K | 0.01% | 598 |
|
|
2021
Q4 | $1.89M | Buy |
14,644
+848
| +6% | +$104K | 0.01% | 553 |
|
|
2021
Q3 | $1.67M | Buy |
13,796
+8,048
| +140% | +$979K | 0.01% | 569 |
|
|
2021
Q2 | $647K | Hold |
5,748
| – | – | ﹤0.01% | 760 |
|
|
2021
Q1 | $549K | Sell |
5,748
-292
| -5% | -$26.6K | ﹤0.01% | 777 |
|
|
2020
Q4 | $480K | Hold |
6,040
| – | – | ﹤0.01% | 759 |
|
|
2020
Q3 | $374K | Buy |
6,040
+148
| +3% | +$9.63K | ﹤0.01% | 771 |
|
|
2020
Q2 | $389K | Hold |
5,892
| – | – | ﹤0.01% | 738 |
|
|
2020
Q1 | $279K | Hold |
5,892
| – | – | ﹤0.01% | 754 |
|
|
2019
Q4 | $323K | Buy |
5,892
+396
| +7% | +$20.8K | ﹤0.01% | 851 |
|
|
2019
Q3 | $269K | Hold |
5,496
| – | – | ﹤0.01% | 886 |
|
|
2019
Q2 | $286K | Hold |
5,496
| – | – | ﹤0.01% | 879 |
|
|
2019
Q1 | $273K | Buy |
+5,496
| New | +$247K | ﹤0.01% | 877 |
|
|
2018
Q4 | – | Sell |
-5,496
| Closed | -$280K | – | 1130 |
|
|
2018
Q3 | $280K | Hold |
5,496
| – | – | ﹤0.01% | 877 |
|
|
2018
Q2 | $203K | Buy |
+5,496
| New | +$210K | ﹤0.01% | 1045 |
|
Other funds holding TECH
HI
CIBC Asset Management's TECH Position: Q2 2026 in Review
CIBC Asset Management reduced its Bio-Techne (TECH) stake by 1% in Q2 2026, selling an estimated $19K and leaving 34,505 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #633.
CIBC Asset Management first reported a position in TECH in Q2 2018 and has held it in 32 quarters since. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- CIBC Asset Management held 34,505 shares of Bio-Techne worth $2.44M as of Q2 2026.
- CIBC Asset Management sold 351 Bio-Techne shares in Q2 2026, an estimated $19K.
- Bio-Techne made up 0.01% of CIBC Asset Management's portfolio in Q2 2026, its #633 holding.
- CIBC Asset Management first reported a position in Bio-Techne in Q2 2018 and has held it in 32 quarters since.
- 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.